Clinical Trial

A Study Of Auricular Transcutaneous Vagus Nerve Stimulation In Chronic Dizziness

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to measure the change in dizziness, as measured by change in Dizziness Handicap Inventory (DHI) score, following a 4-week treatment period with auricular transcutaneous vagus nerve stimulation (aTVNS).
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-02-12.
Trial Details
NCT Number NCT07420803
Lead Sponsor Mayo Clinic
Conditions Chronic Dizziness, Persistent Postural Perceptual Dizziness
Enrollment 60 participants
Start Date 2026-03-23
Primary Completion 2027-03 (estimated)
Study Completion 2027-03 (estimated)
Updated on ClinicalTrials.gov 2026-04-17